Todd C. Davis

This profile gathers the share dealings of Todd C. Davis across 4 companies, led by Ligand Pharmaceuticals Inc, Pelthos Therapeutics Inc. and Biodelivery Sciences International Inc. Over a trading history stretching from 4 June 2021 to 30 June 2026, the count stands at 30 filings.

On the market, this insider has only ever bought: 5 purchases, €602k in total. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 14 share grants and 4 option exercises. In 2026 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €223k. Of 5 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 6 July 2026, the filings show a transaction worth €19k in Ligand Pharmaceuticals Inc. The last purchase on record was published on 15 June 2026, which is 125 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.